GlobeNewswire Inc.··Fibrobiologics, Inc.FibroBiologics Prices $3M Offering, Advances Diabetic Ulcer Drug
FibroBiologics prices $3M offering and validates manufacturing of CYWC628 for diabetic ulcer trials while restoring Nasdaq compliance.
FBLGclinical trialpublic offering